Growth Metrics

CureVac N.V (CVAC) Consolidated Net Income: 2019-2025

Historic Consolidated Net Income for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$68.3 million.

  • CureVac N.V's Consolidated Net Income rose 9.27% to -$68.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.7 million, marking a year-over-year increase of 171.34%. This contributed to the annual value of $173.3 million for FY2024, which is 161.91% up from last year.
  • According to the latest figures from Q2 2025, CureVac N.V's Consolidated Net Income is -$68.3 million, which was down 26.83% from -$53.9 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Consolidated Net Income registered a high of $318.6 billion during Q2 2021, and its lowest value of -$467.1 billion during Q4 2021.
  • Over the past 3 years, CureVac N.V's median Consolidated Net Income value was -$70.8 million (recorded in 2023), while the average stood at -$22.0 million.
  • Examining YoY changes over the last 5 years, CureVac N.V's Consolidated Net Income showed a top increase of 135,019,749.14% in 2021 and a maximum decrease of 713,346.98% in 2021.
  • Over the past 5 years, CureVac N.V's Consolidated Net Income (Quarterly) stood at -$467.1 billion in 2021, then surged by 99.97% to -$131.1 million in 2022, then climbed by 28.81% to -$93.3 million in 2023, then fell by 16.53% to -$108.7 million in 2024, then climbed by 9.27% to -$68.3 million in 2025.
  • Its Consolidated Net Income was -$68.3 million in Q2 2025, compared to -$53.9 million in Q1 2025 and -$108.7 million in Q4 2024.